2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
16
Prostatic Neoplasms
4
Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Peripheral Nervous System Diseases
2
Pain
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Cardiovascular Diseases
2
Breast Carcinoma In Situ
2
Arthralgia
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Radiation Injuries
1
Psoriasis
1
Polyps
1
Polycystic Ovary Syndrome
1
Pelvic Inflammatory Disease
1
Ovarian Neoplasms
1
Osteoarthritis
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Interventions
rofecoxib
1
acetaminophen, codeine drug combination
1
World Health Organization oral rehydration solution
1
Vitamin D
1
Syringes
1
Oxycodone
1
Nutrition Assessment
1
Naloxone
1
Inosine Monophosphate
1
Injections, Intra-Articular
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Duration of Therapy
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteoarthritis
×
Fatty Acids, Omega-3
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts